Current smoking predicts inadequate response to methotrexate monotherapy in rheumatoid arthritis patients naïve to DMARDs: Results from a retrospective cohort study

Identifying predictors of inadequate response to methotrexate (MTX) in rheumatoid arthritis (RA) is key to move from a “trial and error” to a “personalized medicine” treatment approach where patients less likely to adequately respond to MTX monotherapy could start combination therapy at an earlier s...

Descripción completa

Detalles Bibliográficos
Autores principales: Floris, Alberto, Perra, Daniela, Cangemi, Ignazio, Congia, Mattia, Chessa, Elisabetta, Angioni, Maria Maddalena, Mangoni, Arduino Aleksander, Erre, Gian Luca, Mathieu, Alessandro, Piga, Matteo, Cauli, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
6900
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084001/
https://www.ncbi.nlm.nih.gov/pubmed/33907096
http://dx.doi.org/10.1097/MD.0000000000025481

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084001/
https://www.ncbi.nlm.nih.gov/pubmed/33907096
http://dx.doi.org/10.1097/MD.0000000000025481

Ejemplares similares